End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,385 KRW | -3.25% | -0.21% | -41.26% |
Apr. 25 | Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference | CI |
2023 | Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana | CI |
Sales 2022 | 542M 396K | Sales 2023 | 2.73B 2M | Capitalization | 150B 110M |
---|---|---|---|---|---|
Net income 2022 | -13.68B -10M | Net income 2023 | -16.32B -11.93M | EV / Sales 2022 | 182 x |
Net Debt 2022 | 140M 103K | Net cash position 2023 | 11.81B 8.63M | EV / Sales 2023 | 50.5 x |
P/E ratio 2022 |
-6.92
x | P/E ratio 2023 |
-6.66
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.44% |
1 day | -3.25% | ||
1 week | -0.21% | ||
Current month | +3.25% | ||
1 month | -3.05% | ||
3 months | -27.40% | ||
6 months | -55.59% | ||
Current year | -41.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chan-Young Im
CEO | Chief Executive Officer | 45 | 15-11-30 |
Ri-Hyeon Kim
DFI | Director of Finance/CFO | 42 | 20-04-30 |
Dong-Young Lee
CTO | Chief Tech/Sci/R&D Officer | 45 | 15-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chan-Young Im
CEO | Chief Executive Officer | 45 | 15-11-30 |
Dong-Young Lee
CTO | Chief Tech/Sci/R&D Officer | 45 | 15-11-30 |
Kyung-Hwan Kim
BRD | Director/Board Member | 45 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2,385 | -3.25% | 285,087 |
24-05-09 | 2,465 | -3.71% | 322,679 |
24-05-08 | 2,560 | -1.35% | 361,329 |
24-05-07 | 2,595 | +8.58% | 1,281,834 |
24-05-03 | 2,390 | 0.00% | 276,184 |
End-of-day quote Korea S.E., May 09, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-41.26% | 64.34M | |
-27.67% | 9.87B | |
+34.87% | 3.07B | |
-17.30% | 2.73B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- A376930 Stock